Octagon Capital Advisors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839435

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 26 positions · Total reported value $640.61M · Top-10 concentration 73.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.5% · 2 new · 14 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -23.3% · vs SPY -25.4% · Prev Value $1.11B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -9.9% · vs SPY -12.0% · Latest Value $750.61M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, Octagon Capital Advisors LP disclosed 26 equity positions with a combined reported value of $640.61M. The filing implies a focused portfolio: its ten largest positions account for 73.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were ABVX ($112.49M), DNTH ($95.10M), GOSS ($44.84M). By sector, the heaviest allocations are Health Care 81.2%, Other 18.8%. Versus the prior quarter, allocation shifted toward Health Care (+9.2pp) and away from Other (-9.2pp).

Versus the prior quarter, Octagon Capital Advisors LP opened 2 new positions, trimmed 14 and fully exited 3, a turnover rate of 65.5% of positions. The portfolio's overlap with the prior quarter was 65% of names.

The largest new positions opened in Q3 2025 were BBOT ($12.08M), CDTX ($9.58M), PEPG ($3.23M).

Of the 3 positions fully exited versus the prior quarter, the largest were VRNA ($31.87M), SPRY ($23.56M), ATYR ($19.37M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • BBOT BRIDGEBIO ONCOLOGY THERAPEUT · $12.08M
  • CDTX CIDARA THERAPEUTICS INC COM NEW · $9.58M
  • PEPG PEPGEN INC · $3.23M
  • GPCR STRUCTURE THERAPEUTICS INC · $3.22M

Fully Exited (vs previous quarter)

  • VRNA VERONA PHARMA PLC · prev qtr: $31.87M
  • SPRY ARS PHARMACEUTICALS INC · prev qtr: $23.56M
  • ATYR ATYR PHARMA INC · prev qtr: $19.37M
  • TRML TOURMALINE BIO INC · prev qtr: $14.47M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $6.99M
  • HLXB HELIX ACQUISITION CORP II · prev qtr: $2.66M
  • KLRS KALARIS THERAPEUTICS INC · prev qtr: $961.20K
  • ERAS ERASCA INC · prev qtr: $889.00K · history

Insider Transactions (Form 4)

Latest Octagon Capital Advisors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Octagon Capital Advisors LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 26 US equity positions with a combined value of $750.61M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118554 (status: Approved), registered 2020-04-27
  • Regulatory AUM (Form ADV): $1.18B as of 2026-03-20
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 1 hedge funds
  • Website: octagoninvestments.com

Portfolio Structure

  • 26 positions · $750.61M reported value (Q3 2026)
  • Top 10 holdings = 82.5% of reported value
  • Largest position: DNTH (DIANTHUS THERAPEUTICS INC) at 19.8%
  • Average position size: $28.87M

Sector Tilt

  • Health Care 99.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 new, 1 added, 14 reduced, 3 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.2%
Other 18.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.32M $112.49M 17.56%
17.56%
Add
2 2.42M $95.10M 14.85%
14.85%
Add
3 17.05M $44.84M 7.00%
7.00%
Reduce
4 2.87M $41.27M 6.44%
6.44%
Add
5 1.97M $36.37M 5.68%
5.68%
Add
6 2.62M $30.67M 4.79%
4.79%
Add
7 9.07M $29.65M 4.63%
4.63%
Reduce
8 308.00K $29.00M 4.53%
4.53%
Reduce
9 2.81M $25.76M 4.02%
4.02%
Reduce
10 2.13M $25.11M 3.92%
3.92%
Hold
11 903.50K $20.45M 3.19%
3.19%
Hold
12 360.00K $20.38M 3.18%
3.18%
Add
13 830.00K $20.13M 3.14%
3.14%
Reduce
14 722.60K $18.03M 2.81%
2.81%
Add
15 1.27M $15.51M 2.42%
2.42%
Hold
16 1.11M $14.10M 2.20%
2.20%
Hold
17 1.04M $12.08M 1.89%
1.89%
New
18 1.02M $10.18M 1.59%
1.59%
Hold
19 2.63M $9.74M 1.52%
1.52%
Reduce
20 100.00K $9.58M 1.50%
1.50%
New
21 177.67K $4.61M 0.72%
0.72%
Hold
22 252.00K $4.37M 0.68%
0.68%
Reduce
23 1.00M $4.36M 0.68%
0.68%
Hold
24 700.00K $3.23M 0.51%
0.51%
New
25 115.00K $3.22M 0.50%
0.50%
New
26 104.11K $385.21K 0.06%
0.06%
Reduce

FAQ

What did Octagon Capital Advisors LP buy in 2025-Q3?

In its 2025-Q3 13F filing, Octagon Capital Advisors LP reported 26 equity positions worth $640.61M in aggregate; its largest disclosed positions were ABVX ($112.49M), DNTH ($95.10M), GOSS ($44.84M).

How large is Octagon Capital Advisors LP's portfolio?

Octagon Capital Advisors LP reported $640.61M of long equity holdings across 26 positions as of 2025-Q3. Top-10 holdings account for 73.4% of reported value.

What is Octagon Capital Advisors LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/octagon-capital-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →